Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Clinical trial NCT05578820 · COMPLETED

Trial details

NCT number: NCT05578820
Sponsor: Gene Surgery LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sarcoma Melanoma Squamous Cell Carcinoma of Head and Neck Breast Neoplasms Uterine Cervical Neoplasms Vulvar Neoplasms Penile Neoplasms Anus Neoplasms

Start date: 2022-01-01
Primary completion: 2024-04-11
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.